CONNECT WITH US
Fintech

Fintech

AI Startup Tom Health Cuts ER Trips by 28%

PYMNTS – Fintech logo

Published on

Add as a preferred source on Google
AI Startup Tom Health Cuts ER Trips by 28%

Tom Health uses conversational AI to monitor patients between doctor visits, check symptoms, manage medications and connect patients with clinicians when human intervention is needed.

Emergency department visits fell 28%, medication adherence reached 94% and annual wellness visits rose 56%, according to the company.

Sixty percent of healthcare firms use AI chatbots and virtual agents, PYMNTS Intelligence found, as healthcare companies expand AI-powered patient support beyond traditional doctor visits.

A patient with a chronic condition may notice a new symptom or a medication question between visits. Tom Health, an artificial intelligence (AI)-powered primary care platform, is built to handle that gap with an AI care team member that stays in touch. Tome Health is spun out Lumeris, a value-based care company. Lumeris launched Tom Health on Monday (Nov. 16) as a separate company. Tom Health already works with healthcare organizations in 14 states.

Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

The product is Tom, a conversational AI that acts as a member of the primary care team. Tom monitors patients, manages medications and schedules preventive care. When a patient needs a person, it hands the case to a clinician.

Ochsner Health in Louisiana shows how that looks to a patient. Its patient-facing assistant, Mia, runs on Tom. Mia talks with patients, helps them find services and coordinate care, and routes them to human care team members when needed, Tom Health said in its launch announcement.



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.